Daniel S. Herman, MD, PhD, describes efforts at the Penn Center for Precision Medicine to create a dynamic automated system that will collate and interpret a patient’s medical record in real time to discover patients with undiagnosed primary aldosteronism, a known contributor to chronic uncontrolled hypertension. Dr. Herman is an Assistant Professor of Pathology and Laboratory Medicine at Penn Medicine.
Related Links:
Enrolling Clinical Trials: SPYRAL HTN - Renal Denervation with or without Antihypertensive Therapy
Dr Herman’s Profile
Published
February 13, 2018
Created by
BROADCASTMED